N-desmethyl levomepromazine
    25.
    发明申请
    N-desmethyl levomepromazine 审中-公开
    N-去甲基左美丙嗪

    公开(公告)号:US20050080076A1

    公开(公告)日:2005-04-14

    申请号:US10681431

    申请日:2003-10-08

    CPC分类号: A61K31/382 C07D279/28

    摘要: A pharmaceutically active N-desmethyl levomepromazine (abbreviated NDM LMP) and method of use. NDM LMP has substantially the same therapeutic effects as the parent levomepromazine but is subject to less disposition (e.g. presystemic and systemic metabolism) and thus has improved properties over the parent.

    摘要翻译: 药物活性N-去甲基左美丙嗪(缩写为NDM LMP)及其使用方法。 NDM LMP具有与母体左美他嗪基本上相同的治疗效果,但是受到较少的处置(例如系统和全身代谢),因此具有比母体更好的性质。

    Phenothiazine derivatives, their preparation and pharmaceutical
compositions containing them
    27.
    发明授权
    Phenothiazine derivatives, their preparation and pharmaceutical compositions containing them 失效
    吩噻嗪衍生物,其制备方法和含有它们的药物组合物

    公开(公告)号:US5321026A

    公开(公告)日:1994-06-14

    申请号:US825753

    申请日:1992-01-27

    CPC分类号: C07D279/28

    摘要: New phenothiazine derivatives of general formula (I) in whichR represents 4- to 6-membered cycloalkyl, or represents --CH.sub.2 R" in which R" is hydrogen, alkyl containing 1 to 5 carbon atoms, alkenyl or alkynyl containing 2 to 4 carbon atoms, cycloalkyl (3- to 6-membered), phenyl, optionally substituted (with 1 or 2 halogen atoms or with a hydroxyl, alkyl, alkyloxy, trifluoromethyl or nitro radical) or heterocyclic selected from furyl, thienyl or pyridyl, andR' either represents a radical of general formula (IIa) in which R.sub.1 and R.sub.2, which may be identical or different, are alkyl, cycloalkylalkyl, hydroxyalkyl or acetyloxyalkyl or, together with the nitrogen atom to which they are attached, form a saturated or partially unsaturated 4- to 7-membered heterocycle optionally substituted with 1 or 2 alkyl, hydroxyalkyl or acetyloxyalkyl radicals, andR.sub.3 is phenethyl or alkyl optionally substituted with cycloalkyl (3 to 6 carbons) or benzoyl, or represents a radical of general formula (IIb) in which R.sub.1 and R.sub.2 are defined as above.The new products are useful as antispasmodics. ##STR1##

    摘要翻译: 通式(I)的新吩噻嗪衍生物,其中R表示4-至6-元环烷基,或表示其中R“为氢的-CH 2 R”,含有1至5个碳原子的烷基,含有2至4个碳原子的烯基或炔基 碳原子,环烷基(3-至6-元),苯基,任选取代的(具有1或2个卤素原子或与羟基,烷基,烷氧基,三氟甲基或硝基)或选自呋喃基,噻吩基或吡啶基的杂环,R “表示通式(IIa)的基团,其中可以相同或不同的R 1和R 2是烷基,环烷基烷基,羟基烷基或乙酰氧基烷基,或者与它们连接的氮原子一起形成饱和或部分 任选被1或2个烷基,羟基烷基或乙酰氧基烷基取代的不饱和4-至7-元杂环,R 3为任选被环烷基(3-6个碳)或苯甲酰基取代的苯乙基或烷基,或表示通式(IIb)的基团, 在 其中R1和R2如上定义。 新产品可用作解痉药。 (I)(IIa)(IIb)

    Fluoropheno-thiazine and pharmaceutical use
    28.
    发明授权
    Fluoropheno-thiazine and pharmaceutical use 失效
    氟苯噻嗪和药物用途

    公开(公告)号:US4681878A

    公开(公告)日:1987-07-21

    申请号:US888278

    申请日:1986-07-23

    申请人: John D. McDermed

    发明人: John D. McDermed

    IPC分类号: C07D279/28 A61K31/54

    CPC分类号: C07D279/28

    摘要: The compound 2-[10-(2-Dimethylaminopropyl)-7-fluoro-2-phenothiazinyl]-2-methylpropionic acid or a pharmaceutically acceptable salt thereof. The compound or salt are useful as antihistamines.

    摘要翻译: 化合物2- [10-(2-二甲基氨丙基)-7-氟-2-吩噻嗪基] -2-甲基丙酸或其药学上可接受的盐。 化合物或盐可用作抗组胺剂。

    Substituted 2H-1,4-benzothiazin-3(4H)-ones
    30.
    发明授权
    Substituted 2H-1,4-benzothiazin-3(4H)-ones 失效
    取代的2H-1,4-苯并噻嗪-3(4H) - 酮

    公开(公告)号:US4078062A

    公开(公告)日:1978-03-07

    申请号:US736620

    申请日:1976-10-28

    申请人: John Krapcho

    发明人: John Krapcho

    CPC分类号: C07D279/16

    摘要: Compounds of the following formula and their pharmaceutically acceptable salts ##STR1## wherein X and X.sub.1 are independently selected from hydrogen, halogen, lower alkyl, lower alkoxy, trifluoromethyl, nitro, or amino; R is hydrogen, lower alkyl, or ##STR2## wherein m is 1, 2, or 3; n is 2, 3, 4, or 5; and B is di(lower alkyl)amino, piperidinyl, pyrrolidinyl, morpholino; or N-lower alkyl-piperazino; are disclosed. These compounds possess antiinflammatory activity.

    摘要翻译: 下式的化合物及其药学上可接受的盐,其中X和X 1独立地选自氢,卤素,低级烷基,低级烷氧基,三氟甲基,硝基或氨基; R是氢,低级烷基或者其中m是1,2或3; n为2,3,4或5; 和B是二(低级烷基)氨基,哌啶基,吡咯烷基,吗啉代; 或N-低级烷基 - 哌嗪子基; 被披露。 这些化合物具有抗炎活性。